AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06176846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality Exergaming Program
Description: Oculus Quest 3 glasses will be used as hardware for the IVR exergame program, and Boxing, HIIT, Combat, Sculpt and Dance, among the Fit-XR games that offer virtual reality experience for fitness, will be selected according to the physical fitness level of the subjects and personalized multicomponent ( balance, strength, agility, endurance) IVR exergame program will be created. The exercise program is limited to 25-30 minutes a day and will be applied 2 days a week for 8 weeks in the clinic under the supervision of a physiotherapist. The exergaming program will be progressed according to the difficulty level, duration and technical characteristics of the games.
Study NCT06176846 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Program
Description: In the home-based exercise program, a personalized multicomponent (balance, strength, agility, endurance) exercise program will be applied according to the physical fitness level of the subjects. The exercises will progress by increasing the difficulty level and number of repetitions of the exercises. An e-brochure will be given to the subjects for the exercises, the exercises will be shown to the subjects on the 1st day, and exercise control will be carried out in the 1st week and the 4th week.
Study NCT05834270 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Single dose tamsulosin 0.4mg
Description: Single dose tamsulosin 0.4mg
Study NCT05834270 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Double dose tamsulosin 0.4mg
Description: Double dose tamsulosin 0.4mg
Study NCT06018974 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Yetitablet gaming
Description: Playing digital games like bowling, memory games, coordination games ect. with the Yetitablet.
Study NCT06514690 — intervention group
Intervention type: OTHER
Intervention: Sedation
Description: Different degrees of intravenous sedation according to the Ramsay scale
Study NCT04483635 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Weekly oral dose of placebo
Study NCT04483635 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Weekly oral dose of Vitamin D
Study NCT04814030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1 inhibitor
Description: Transarterial hepatic chemoembolization and FOLFOX-based infusion
Study NCT06394349 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: PRP+308nm
Description: PRP+308nm
Study NCT06394349 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: NS+308nm
Description: NS+308nm
Study NCT06309927 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Operative hysteroscopy (by tissue removal device)
Description: Surgical evacuation of the uterine cavity using the Truclear Mini-Elite hysteroscopic tissue removal device
Study NCT06493175 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Application of large language model in emergency chest pain triage.
Description: The large language model MedGuide-V5 is able to quickly extract key information from a patients description, and by analyzing these descriptions, it provides physicians with a possible initial diagnosis to help them quickly prioritize the treatment of patients.
Study NCT06493175 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: According to the normal procedures to receive medical treatment
Description: After the artificial intelligence system evaluation, the patients will receive the diagnosis and treatment according to the normal procedure. The overall time of artificial triage, the triage of patients, and other data will be recorded. Patient visits should not be delayed by the use of artificial intelligence systems for evaluation.
Study NCT05576298 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Insulin degludec injection, RD15003
Description: single dose, s.c. injection
Study NCT05576298 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Insulin degludec, Tresiba
Description: single dose, s.c. injection
Study NCT05940064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib, Polatuzumab Vedotin, Rituximab
Description: Drug: Zanubrutinib, Polatuzumab Vedotin and Rituximab Zanubrutinib（Z）160 mg bid po Day 1-21; Polatuzumab Vedotin（P）1.8 mg/kg ivgtt D1; Rituximab（R）375 mg/m\^2 ivgtt D1
Study NCT06071598 — intervention group
Intervention type: OTHER
Intervention: Surgical specimens of CRC-affected patients
Description: Specimens of CRC-affected patients will be collected during the surgery, without other risks for the patients, since we will use only material left after pathologist analysis
Study NCT04973891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canagliflozin combined with metformin
Description: Canagliflozin, a novel glucose-lowering medication, has been shown to have positive effects on reducing body weight, blood pressure and cardiovascular events.~Metformin, a classical and common insulin sensitizer that can reduce both hyperinsulinemia and hyperandrogenemia, is widely used for patients with PCOS.
Study NCT04973891 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: Metformin, a classical and common insulin sensitizer that can reduce both hyperinsulinemia and hyperandrogenemia, is widely used for patients with PCOS.
Study NCT06193694 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching
Description: Formal coaching program followed by the Coaching Fidelity Tool, to be taken by the study group after program completion contains 12 questions, predominantly multiple choice and yes/no, although there is one question that requires a short answer as well as a place to write additional comments. These questions are meant to elicit responses about their experience with their assigned coach during their one-on-one coaching sessions.
Study NCT05190744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PB
Description: 500mg twice daily (BID) followed by 1000mg BID. The dose of PB inducing the maximal increase in urine osmolality will be continued for up to three months providing that no side effects are observed including clinical and laboratory surveillance.
Study NCT05244538 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality distraction
Description: Patients will be exposed to a virtual reality representing a forest walk. A reduction of at least 50 percent in the remifentanil and propofol doses required for oocyte retrieval is expected.
Study NCT05244538 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol-remifentanil sedation
Description: Target controlled infusion (TCI) of remifentanil will be started at an effect concentration (Ce) of 1.5 ng/mL and TCI propofol at Ce 1.5 ug/mL.~The concentration of remifentanil will be adjusted in 0.5 ng/ml increments based on hand sign from the patient with a maximum effect concentration of remifentanil at 2.5 ng/ml.
Study NCT05320328 — intervention group
Intervention type: DEVICE
Intervention: Radio frequency ablation
Description: Radiofrequency ablation (RFA) uses heat to kill cancer cells. High-frequency electrical currents are passed through a special needle or probe called a needle electrode. The electrical current from the probe heats a small area containing cancer cells to high temperatures, killing the cancer cells. The area around the tumour is also usually treated because it may contain cancer cells.
Study NCT04890106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Test - Bimatoprost 0.01% Ophthalmic Solution
Description: Subjects in one arm will receive one drop of the test drug in both the eyes every evening at approximately 10:00 pm ± 2 hours for 42 days.
Study NCT04890106 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
Description: Subjects in the second arm will receive one drop of the reference drug in both the eyes every evening at approximately 10:00 pm ± 2 hours for 42 days.
Study NCT04370730 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: clinical, neuroimaging and DNA assessments
Description: Selected assessments, including evaluation of treatment response to specific antipsychotic drugs, will be performed at follow-up visits after 1, 3 and 5 years
Study NCT05801198 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Artemisia afra or Annua 10g oral infusion/tea per day for 14 days
Description: Participants will be recruited after completing standard malaria treatment, and those who have a positive qRT-PCR for plasmodium gametocyte reservoirs will be randomly assigned to either artemisia afra tea, or artemisia annua tea or into the control group with no intervention
Study NCT06343272 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: EAA supplementation
Description: The experimental group will receive the mixture (Amino-Ther® PRO, Professional Dietetics, Milan) composed of (in mg): L-leucine 1200, l L-isine 900, L-threonine 700, L-isoleucine 600, L-valine 600, L-cystine 150, L histidine 150, L-phenylalanine 100, L-methionine 50, L-tryptophan 50, vitamin B6 0.85, vitamin B1 0.70, citric acid 409, acidomalic 102.5, succinic acid 102.5.~1 sachet dissolved in 150 ml of water at 10.00 am +1 sachet at 4.00 pm daily for 60 days There are: proteins 0.00 g, carbohydrates 2.1 g, fats 0.00 g
Study NCT06343272 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Isocaloric placebo
Description: The control group will take 25g of maltodextrins daily with the same methods as the treated group: 1 sachet dissolved in 150 ml of water at 10.00 am +1 sachet at 4.00 pm daily for 60 days
Study NCT05459038 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: C-Arm Rotational View (CARV)
Description: CARV includes predefined fluoroscopy landmarks of the uninjured side to correct for rotational malalignment of the injured side in which the rotation of the C-Arm Image Intensifier is used
Study NCT06394557 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: In-office Dental Bleaching Conventional
Description: Participants will undergo 2 sessions of in-office dental bleaching, using a 35% Hydrogen Peroxide bleaching gel, with 7 days of interval between sessions. Bleaching gel will be used in 3 15-minutes applications as indicated by the manufacturer. A 2% Potassium Nitrate and Sodium Fluoride desensitizing gel will be applied 15 minutes before the dental bleaching procedure, in both sessions.
Study NCT06394557 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: In-office Dental Bleaching Alternative
Description: Participants will undergo 2 sessions of in-office dental bleaching, using a 35% Hydrogen Peroxide bleaching gel, with 2 days of interval between sessions. Bleaching gel will be used in 3 15-minutes applications as indicated by the manufacturer. A 2% Potassium Nitrate and Sodium Fluoride desensitizing gel will be applied 15 minutes before the dental bleaching procedure, in both sessions.
Study NCT06213610 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Perindopril tablet
Description: Perindopril is manufactured by Pharmtechnology LLC, Republic of Belarus. Each tablet contains 8 mg of perindopril tert-butylamine.
Study NCT06213610 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Prestarium® A tablet
Description: Prestarium® A is manufactured by Les Laboratoires Servier Industrie, France. Each tablet contains 10 mg of perindopril arginine.
Study NCT06392750 — intervention group
Intervention type: BEHAVIORAL
Intervention: Collection of tumor tissue specimens
Description: Collection of tumor tissue specimens during surgery
Study NCT04800471 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smart insulin pens and CGM
Description: Participants in this group will be monitored by Smart Insulin pens and Continuous Glucose Monitoring Devices
Study NCT04800471 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Point of Care Glucose Group
Description: Participants in this group will be monitored by POC glucose values.
Study NCT04961086 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: energy drink
Description: An easily available 250 ml branded energy drink will be randomized to the partcipants after informed consent. Before and thirty minutes after drinking the given energy drink the participant cognition, heart rate, blood pressure and blood glucose will be measured.
Study NCT04961086 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: energy drink
Description: An easily available 250 ml branded energy drink will be randomized to the partcipants after informed consent. Before and thirty minutes after drinking the given energy drink the participant cognition, heart rate, blood pressure and blood glucose will be measured.
Study NCT05163067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise and cognitive training program
Description: Participants will take part in a combined aerobic exercise and cognitive training program. The program will include moderate cycling exercise and cognitive game resolving at the same time. The tasks will be instructed and supervised by a fitness expert and a trained clinical neuropsychologist.
Study NCT06309927 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Suction curettage
Description: Surgical evacuation of the uterine cavity with electrical vacuum suction curette
Study NCT04972123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPC - Capsaicin, Phenylephrine, Caffeine
Description: CPC is a combination of Capsaicin, Phenylephrine and Caffeine
Study NCT04972123 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Tilt Table Test
Description: Participant will undergo tilt tablet testing using the Italian protocol (see reference section). The Italian protocol includes 20 minutes of passive tilt at 70 degrees (Passive Phase) followed by nitroglycerin (NTG) administration and tilt testing for another 15 minutes (NTG Phase).
Study NCT04972123 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Tilt Table Test
Description: Participant will undergo tilt tablet testing using the Italian protocol (see reference section). The Italian protocol includes 20 minutes of passive tilt at 70 degrees (Passive Phase) followed by nitroglycerin (NTG) administration and tilt testing for another 15 minutes (NTG Phase).
Study NCT04972123 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for CPC
Study NCT05912283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synthetic Nitrile Condoms (53mm)
Description: 53mm width synthetic nitrile condoms
Study NCT05912283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synthetic Nitrile Condoms (56mm)
Description: 56mm width synthetic nitrile condoms
Study NCT05912283 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control Latex Condom
Description: Commercial natural rubber latex condom
Study NCT05473455 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Experimental: Follicular aspiration with addition of follicular flushing.
Description: Follicular flushing if necessary up to 5 times using a double lumen needle for oocyte recovery
Study NCT05748301 — intervention group
Intervention type: OTHER
Intervention: AI Clinician
Description: N/A - Study is observational study testing the feasibility of running the AI Clinician in real time.
Study NCT05881681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-Delivered Mindfulness Training (MT)
Description: Unwinding Anxiety is an app-delivered mindfulness training program which includes a progression through 30+ daily modules. Each module's training is delivered via short video tutorials and animations (\~10 min/day). Each training builds on the previous one; modules are 'locked' so that they can only be viewed at a pace of 1/day (previous modules can be reviewed at any time). A built-in self-assessment is taken after every seven modules to ensure key concepts are learned before moving on with automated suggestions on which modules to repeat based on the self-assessment results. User-initiated guided practices range from short exercises (30 seconds) to manage anxiety the moment it arises to formal guided meditations (up to 15 minutes), and can be accessed at any time
Study NCT04963023 — intervention group
Intervention type: OTHER
Intervention: Physical examinations
Description: BPCO physical examinations
Study NCT04963023 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: blood test
Description: blood test in order to study immunologic markers
Study NCT04836611 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: 1 blood sample
Description: 2 groups of subjects (group 1 : with diagnosis of CHS - group 2 : no diagnosis of CHS) will have 2 blood and 1 urine samples + 1 questionnaire
Study NCT05204095 — intervention group
Intervention type: DEVICE
Intervention: Portable slit-lamp photography
Description: The enrolled patients will undergo portable slit-lamp photography with and without mydriasis and receive traditional slit-lamp photography for comparison.
Study NCT06007547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Poractant Alfa
Description: Poractant alfa (Curosurf) 200mg/kg administered under direct laryngoscopy using a surfactant instillation catheter
Study NCT06007547 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Poractant Alfa
Description: Poractant alfa (Curosurf) 200mg/kg administered under direct laryngoscopy using a surfactant instillation catheter
Study NCT05279365 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfizer/BioNTech (BNT162b2)
Description: participants will receive a booster dose (1st booster or 2nd booster) of vaccine
Study NCT05279365 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Moderna
Description: participants will receive a booster dose (1st booster or 2nd booster) of vaccine
Study NCT05215119 — intervention group
Intervention type: PROCEDURE
Intervention: natural cycle endometrial preparation
Description: Cycles will be monitored from either day-10 or-12, according to patient's menstrual cycle length, with serial analysis of blood serum LH and progesterone levels and assessment of dominant follicle growth. In a spontaneous cycle, ovulation will be determined by a LH surge (>20 IU/L) and a corresponding rise in progesterone (>0.8 ng/ml). In a triggered cycle, ovulation will be determined by the administration of an hCG trigger when the dominate follicle reached >16 mm (and LH was \<20 IU/L).
Study NCT05784818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Up To Me Intervention + No Booster
Description: Participants will complete two-hour sessions once a week over three weeks in which they complete modules in the Up To Me Workbook. These sessions are facilitated by a peer facilitator and a member of the USF Counseling center. Other members in the group sessions are university students who are peers who are also experiencing some form of shame around their mental health challenges.
Study NCT05784818 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Up To Me Intervention + Booster
Description: In addition to the Up To Me Intervention, participants also complete a booster/additional session where additional topics of the Up To Me workbook are covered. This additional session occurs four weeks after the completion of the third session.
Study NCT06284291 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: transcranial magnetic stimulation (TMS)
Description: The STM9000 Standard-BI stimulator with 70 mm refrigerated butterfly stimulator (EB Neuro, Florence, Italy) controlled by Galileo Netbrain 9000 hardware and software (EB Neuro, Florence, Italy) is used. EMG data are recorded from the contralateral dorsal first interosseous muscle using gelled surface electrodes. EEG data are recorded by using the BE PLUS PRO Advanced EEG/EMG/EP amplifier (EB Neuro, Florence, Italy IT).
Study NCT05773495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: I-SITE Intervention
Description: I-SITE is a coaching facilitated implementation program that guides clinical personnel through tailored integration of teleophthalmology into primary care workflows.
Study NCT05773495 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care Teleophthalmology
Description: All sites will initially receive usual care teleophthalmology, consisting of having an active teleophthalmology program located in the primary care clinic and access to the I-SITE online toolkit. All sites will utilize non-mydriatic retinal cameras (e.g. Topcon NW400) located in their primary care clinic to obtain a single 45-degree photo of the disc and macula with an anterior photo in each eye to provide diabetic eye screening as part of patients' usual care. Images are captured by trained primary care personnel and securely transmitted to eye doctors for evaluation.
Study NCT05035459 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: lung ultrasound
Description: drug adjustment based on lung ultrasound results
Study NCT05035459 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound
Description: drug adjustment independent on lung ultrasound results
Study NCT04872569 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decision-making tool
Description: Participants will be directed to use the decision tool for 3 months using it at their own pace.~The tool covers topics relevant to women with disabilities in considering or planning a pregnancy and reflects core elements of decision making tools based on the Ottawa Framework for Decision Support.
Study NCT05598905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Description: one capsule of 150mg 90 minutes after 10mg of oxycodone
Study NCT05598905 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oxycodone 10mg
Description: one 10mg tablet
Study NCT05598905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone 10mg
Description: one 10mg tablet
Study NCT05598905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lacosamide 150 mg
Description: one capsule of 150mg 90 minutes after 10mg of oxycodone